Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Tumor ablation · Virginia | Tumor ablation · Florida | |
|---|---|---|
| Surgeons, 2024 | 1 | 3 |
| Medicare fee-for-service cases | 278 | 795 |
| Growth since 2019 (Medicare FFS) | +2.6%/yr | +1.4%/yr |
| Forecast cases (Medicare FFS) | 470 in 2030 | 1,250 in 2030 |
| Forecast growth | +9%/yr to 2030 | +7.8%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 0.3 | 0.4 |
| Medicare Advantage share | 42% | 60% |
| Out of hospital | 0% (+0 pts since 2019) | 0% (+0 pts since 2019) |
| Cases per surgeon | 278 | 265 |
| Top 10 surgeons' share | 100% | 100% |
| Surgeons growing | 1 | 0 |
| New since the base year | 0 | 0 |
| Likely to stop billing it | 0 by 2026 | 0 by 2026 |
| Forecast miss, 1 year (procedure) | 15% | 15% |
| Company payments per surgeon | $714K | $425K |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.